
AI-powered clinical assistant for UK healthcare professionals
What are the key clinical features to consider when diagnosing DiGeorge Syndrome in a child?
Answer
Guideline-Aligned (High Confidence)
Generated by iatroX. Developer: Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner).
Last reviewed: 22 August 2025
Key clinical features to consider when diagnosing DiGeorge syndrome (22q11.2 deletion syndrome) in a child include:
- Congenital heart defects: Most commonly conotruncal anomalies such as tetralogy of Fallot, interrupted aortic arch, and ventricular septal defects are hallmark features and often prompt early investigation 1 (Diniz et al., 2023).
- Immunodeficiency: Due to thymic hypoplasia or aplasia, children may present with recurrent infections or immune dysfunction, which is a critical diagnostic clue (Biggs et al., 2023).
- Facial dysmorphism: Characteristic facial features include a long face, hooded eyelids, small mouth, and low-set ears, which aid clinical suspicion 1 (Purow et al., 2025).
- Hypocalcaemia: Resulting from parathyroid hypoplasia, presenting with seizures or tetany in infancy, is a key biochemical feature 1 (Biggs et al., 2023).
- Developmental delay and neuropsychiatric manifestations: These may include speech delay, learning difficulties, and behavioural problems, which often become apparent in early childhood 1 (Purow et al., 2025).
- Palatal abnormalities: Such as cleft palate or velopharyngeal insufficiency, contributing to feeding difficulties and speech problems 1 (Purow et al., 2025).
These features together form the clinical spectrum that should prompt genetic testing for 22q11.2 deletion. Early recognition is essential for multidisciplinary management and surveillance 1 (Biggs et al., 2023; Diniz et al., 2023; Purow et al., 2025).
Key References
- NG72 - Developmental follow-up of children and young people born preterm
- NG143 - Fever in under 5s: assessment and initial management
- (Biggs et al., 2023): Chromosome 22q11.2 Deletion (DiGeorge Syndrome): Immunologic Features, Diagnosis, and Management.
- (Diniz et al., 2023): Congenital Heart Defects and 22q11.2 Deletion Syndrome: A 20-Year Update and New Insights to Aid Clinical Diagnosis.
- (Purow et al., 2025): Review of the Pathophysiology and Clinical Manifestations of 22q11.2 Deletion and Duplication Syndromes.
Related Questions
Finding similar questions...